INCB16562, a JAK1/2 selective inhibitor, is efficacious against multiple myeloma cells and reverses the protective effects of cytokine and stromal cell support.
暂无分享,去创建一个
J. Fridman | Jun Li | X. Wen | M. Favata | P. Scherle | K. Vaddi | E. Caulder | J. Kelley | R. Sparks | A. Combs | R. Newton | K. Solomon | B. Thomas | A. Arvanitis | James D Rogers